文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

非体外循环冠状动脉旁路移植术联合食管癌切除术与单纯食管癌切除术的长期生存结果。

Long-term survival outcomes of esophagectomy with off-pump CABG versus esophagectomy alone.

机构信息

Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, No. 7 Weiwu Road, Jinshui District, Zhengzhou, 450003, Henan, China.

Department of Thoracic Surgery, Henan Chest Hospital Affiliated to Zhengzhou University, Zhengzhou, China.

出版信息

Surg Endosc. 2024 Jul;38(7):3691-3702. doi: 10.1007/s00464-024-10822-x. Epub 2024 May 23.


DOI:10.1007/s00464-024-10822-x
PMID:38782826
Abstract

BACKGROUND: This study aimed to evaluate the long-term survival outcomes of esophagectomy with off-pump coronary artery bypass grafting (OPCABG) vs. esophagectomy alone. METHODS: A total of 1798 patients who received esophagectomy between January 2010 and February 2020 were included and divided into the 38 patients who underwent OPCABG followed by esophagectomy (OP + ES group) and 1760 patients had only esophagectomy (ES group). Propensity score matching (PSM) and Cox multivariable analyses were performed to compare postoperative complications, disease-free survival (DFS), and overall survival (OS) between the two groups. RESULTS: There were 37 patients in the OP + ES group matched with 74 in the ES group. The matched OP + ES group had higher total postoperative complications than the ES group, especially more pulmonary infections (P = 0.001) and arrhythmias (P = 0.018), but no other postoperative complications were the difference. The DFS was similar and the OS was a significant difference between the matching 2 groups (log-rank, P = 0.132 and 0.04, respectively). Although pT 3/4 stage, pN (+), and tumor length > 3.0 cm were independently associated with worse OS and DFS in multivariable analysis, CAD and EF < 55% were also found to be a predictive factor for OS and DFS in univariate analysis. CONCLUSION: OPCABG followed by esophagectomy for esophageal cancer associated with coronary artery disease has equivalent DFS and recurrence pattern to esophagectomy for esophageal cancer alone, but with a disadvantage in OS.

摘要

背景:本研究旨在评估非体外循环冠状动脉旁路移植术(OPCABG)联合食管癌切除术与单纯食管癌切除术的长期生存结局。

方法:共纳入 1798 例 2010 年 1 月至 2020 年 2 月期间接受食管癌切除术的患者,分为接受 OPCABG 联合食管癌切除术的 38 例患者(OP+C 组)和仅接受食管癌切除术的 1760 例患者(ES 组)。采用倾向评分匹配(PSM)和 Cox 多变量分析比较两组术后并发症、无病生存(DFS)和总生存(OS)。

结果:OP+C 组有 37 例患者匹配 ES 组的 74 例患者。匹配后的 OP+C 组总术后并发症发生率高于 ES 组,尤其是肺部感染(P=0.001)和心律失常(P=0.018),但其他术后并发症无差异。DFS 相似,OS 两组有显著差异(log-rank,P=0.132 和 0.04)。虽然 pT3/4 期、pN(+)和肿瘤长度>3.0cm 在多变量分析中与 OS 和 DFS 较差相关,但 CAD 和 EF<55%在单变量分析中也被发现是 OS 和 DFS 的预测因素。

结论:与单纯食管癌切除术相比,合并冠心病的食管癌患者行 OPCABG 联合食管癌切除术具有相似的 DFS 和复发模式,但 OS 较差。

相似文献

[1]
Long-term survival outcomes of esophagectomy with off-pump CABG versus esophagectomy alone.

Surg Endosc. 2024-7

[2]
The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis.

J Cancer Res Clin Oncol. 2020-3-17

[3]
Survival and Mid-Term Outcomes of On Pump vs. Off Pump Coronary Artery Bypass Grafting: A Propensity Score-Matched Analysis in A First Peruvian Registry.

Braz J Cardiovasc Surg. 2024-11-28

[4]
Predictive Value of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve for Survival in Patients with Esophageal Cancer Following Esophagectomy.

J Gastrointest Cancer. 2025-8-29

[5]
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.

J Cancer Res Clin Oncol. 2022-4

[6]
Impact of Anastomotic Leaks on Long-Term Survival in Patients with Esophageal Squamous Cell Carcinoma Following McKeown Esophagectomy: A Propensity Score-Matched Analysis.

Ann Surg Oncol. 2025-4-8

[7]
Coronary Artery Bypass Grafting Plus Mitral Valve Plasty May Not Provide More Advantage in Patients with Coronary Heart Disease and Moderate Ischemic Mitral Regurgitation: An Inverse Probability of Treatment Weighting Retrospective Cohort Study.

Braz J Cardiovasc Surg. 2024-11-28

[8]
A Propensity-Score Matched Analysis to Evaluate Local Treatment Modalities for Esophageal Squamous Cell Carcinoma in Over 80 years on A SEER Database.

Clin Interv Aging. 2025-8-9

[9]
Left compared with right thoracic approach thoracotomy in esophageal cancer: a retrospective cohort study.

J Cancer Res Clin Oncol. 2023-9

[10]
Technical feasibility and oncological outcomes of robotic esophagectomy compared with conventional thoracoscopic esophagectomy for clinical T3 or T4 locally advanced esophageal cancer: a propensity-matched analysis.

Surg Endosc. 2024-7

本文引用的文献

[1]
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer.

J Transl Med. 2023-9-19

[2]
Tri-modality therapy in advanced esophageal carcinoma: Long-term results and insights from a developing world, institutional cohort.

Br J Radiol. 2023-6

[3]
Patterns of Recurrence and Long-Term Survival of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Locally Advanced Esophageal Cancer Treated with Neoadjuvant Chemotherapy: a Propensity Score-Matched Analysis.

J Gastrointest Surg. 2023-6

[4]
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.

Chin Med J (Engl). 2022-2-9

[5]
Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification.

JACC CardioOncol. 2021-9-21

[6]
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.

JAMA Surg. 2021-5-1

[7]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[8]
Esophagectomy combined with off-pump coronary artery bypass grafting through left posterolateral incision is safe and feasible for esophageal cancer associated with coronary artery disease.

Dis Esophagus. 2021-10-11

[9]
A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.

Ann Surg. 2019-11

[10]
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

Lancet. 2019-9-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索